>_ QFI Terminal
Terminal › Stocks › TAOX

TAO Synergies Inc. (TAOX) Stock

Healthcare · Biotechnology · US
$3.94 -21.83%
Last updated Nov 12, 2026 10:46 UTC

TAOX Key Statistics

Market Cap$12.95M
P/E (TTM)-0.31
P/S (TTM)43.29
P/B (TTM)0.33
Revenue (TTM)$299,061.00
EPS (TTM)$-12.70
Dividend Yield—
ROE (TTM)-182.52%
Net Margin-9,609.23%
Gross Margin100.00%
52W High$7.15
52W Low$3.74
Analyst View—
Price Target—
Employees4
Volume824,162

About TAO Synergies Inc.

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

CEO: Joshua N. Silverman. Company website

TAOX — Frequently Asked Questions

What is the TAOX stock price today?

TAO Synergies Inc. (TAOX) trades at $3.94, down 21.83% on the day, as of Nov 12, 2026 10:46 UTC.

What is TAO Synergies Inc.'s market cap?

TAO Synergies Inc. has a market capitalisation of $12.95M, calculated from the live TAOX share price and shares outstanding.

What is the P/E ratio of TAOX?

TAOX has no meaningful price-to-earnings ratio: TAO Synergies Inc. lost $12.70 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does TAO Synergies Inc. make?

TAO Synergies Inc. generated revenue of $299,061.00 over the trailing twelve months, which puts the stock at 43.29 times sales.

What is the 52-week range for TAOX?

TAOX has traded between $3.74 and $7.15 over the past 52 weeks, and the last price is 44.9% below that high.

Is TAO Synergies Inc. profitable?

No. TAO Synergies Inc. is loss-making, with a net margin of -9,609.23% over the trailing twelve months.

What sector is TAO Synergies Inc. in?

TAO Synergies Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in US .

Who is the CEO of TAO Synergies Inc.?

Joshua N. Silverman is the chief executive of TAO Synergies Inc., which employs 4 people.

Where can I track TAOX in real time?

QFI Terminal shows TAOX with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See TAOX live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open TAOX in Terminal See plans

Biotechnology stocks

REGN Regeneron Pharmaceuticals, Inc. VRTX Vertex Pharmaceuticals Incorporated ONC BeOne Medicines AG INCY Incyte Corporation ALNY Alnylam Pharmaceuticals, Inc. JAZZ Jazz Pharmaceuticals plc ARGX argenx SE GMAB Genmab A/S NBIX Neurocrine Biosciences, Inc. BMRN BioMarin Pharmaceutical Inc. UTHR United Therapeutics Corporation CDT CDT Equity Inc. MRNA Moderna, Inc. EXEL Exelixis, Inc. BNTX BioNTech SE SRPT Sarepta Therapeutics, Inc. HALO Halozyme Therapeutics, Inc. INSM Insmed Incorporated MDGL Madrigal Pharmaceuticals, Inc. TECH Bio-Techne Corporation ASND Ascendis Pharma A/S CAI Caris Life Sciences, Inc. IONS Ionis Pharmaceuticals, Inc. BBIO BridgeBio Pharma, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc.

ETFs holding TAOX

VTI Vanguard Morningstar Total Stock Market ETF 0.00%